CBIH vs CRL: stock comparison and AI forecast
Cannabis Bioscience International Holdings, Inc. (CBIH) and Charles River Laboratories International, Inc. (CRL) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
CBIH Cannabis Bioscience International Holdings, Inc.
- Price
- $0.00 -66.7% · 6M
- Market Cap
- n/a
- P/E Ratio
- –
- AI Forecast
CRL Charles River Laboratories International, Inc.
- Price
- $337.52 +85.8% · 6M
- Market Cap
- $16.11B
- P/E Ratio
- 188.6x
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- Over the last six months CRL returned +85.8% and CBIH -66.7%.
- Both companies share the SEC industry classification Services-Commercial Physical & Biological Research.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | CBIH | CRL |
|---|---|---|
| Market Cap | – | $16.11B |
| P/E Ratio | – | 188.55x |
| P/B Ratio | – | 4.99x |
| EPS | $0.00 | $1.79 |
| Book Value/Share | – | $67.60 |
| Revenue/Share | – | $83.30 |
| FCF/Share | – | $8.37 |
Profitability & Margins
| Metric | CBIH | CRL |
|---|---|---|
| ROA | -31398.1% | – |
| ROIC | 32.3% | 2.5% |
| Gross Margin | 60.3% | – |
| Operating Margin | -379.5% | 4.0% |
| Net Margin | -467.9% | – |
| EBT Margin | -379.5% | 0.9% |
| Tax Rate | 0.0% | -416.1% |
Financial Health
| Metric | CBIH | CRL |
|---|---|---|
| Current Ratio | 0.00x | 1.41x |
| Quick Ratio | – | 1.12x |
| D/E Ratio | – | 1.29x |
| Financial Leverage | – | 2.31x |
| Interest Coverage | -2.7x | 6.5x |
| Working Capital | -$1M | $446M |
Cash Flow
| Metric | CBIH | CRL |
|---|---|---|
| Operating Cash Flow | -$280K | $622M |
| Free Cash Flow | – | $400M |
| Capital Spending | – | -$223M |
| OCF Growth YoY | – | -17.0% |
| FCF Growth YoY | – | -26.5% |
| FCF/Sales | – | 10.1% |
| CapEx/Sales | – | 5.6% |
Operational Efficiency
| Metric | CBIH | CRL |
|---|---|---|
| Asset Turnover | – | 0.53x |
| Receivables Turnover | – | 5.4x |
| Fixed Assets Turnover | – | 2.7x |
| Days Sales Outstanding | – | 67 days |
Income Statement
| Metric | CBIH | CRL |
|---|---|---|
| Total Revenue | – | $3.98B |
| Operating Income | -$390K | $159M |
| Net Income | -$480K | – |
| SG&A Expense | – | $725M |
| Cost of Goods Sold | $40K | – |
Dividend & Shareholder Information
| Metric | CBIH | CRL |
|---|---|---|
| Shares Outstanding | – | 48M |
CBIH vs CRL: stock comparison and AI forecast
Which stock performed better over the last six months, CBIH or CRL?
Over the last six months CRL returned +85.8% and CBIH -66.7%.
Which one does Intratio's AI model rank higher, CBIH or CRL?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.